Exxon Mobil Corporation (XOM), a U.S. oil and gas giant, stated that it has put a hold on its plans for the construction of the blue hydrogen facility in Baytown, TX, intended to be the largest of

Novartis NVS obtained FDA approval for onasemnogene abeparvovec-brve, a gene replacement therapy, for children two years and older, teens, and adults with spinal muscular atrophy (SMA).

The therapy

Just a few months ago, analysts and investors were openly questioning Alphabet’s (GOOGL) future, arguing that large language models would cannibalize search and erode its core business. Today, the

Abercrombie & Fitch Co. ANF posted strong third-quarter fiscal 2025 results, wherein the top and bottom lines beat the Zacks Consensus Estimate. Additionally, on a year-over-year basis, the

Shares of Sarepta Therapeutics SRPT rose 7% on Monday after the company announced its progress on a phase I/II study evaluating SRP-1003, an investigational small interfering RNA (siRNA) therapeutic

Mastercard Incorporated MA is diving deeper into sector-specific commerce innovation, and its latest collaboration with L’Oréal could signal a significant change in how beauty products are financed

Zacks Rank #3 (Hold) stock Apple (AAPL) has undergone dramatic changes throughout its long and storied history. Initially, the company focused on computers, but today, its business primarily

AppLovin Corporation APP and Arm Holdings plc ARM stand out as two tech companies deeply intertwined with the accelerating adoption of artificial intelligence. While both firms operate in very

Canadian National Railway CNI is grappling with challenges significantly impacting its financial stability. The increased operating expenses and weak liquidity are major headwinds hurting the